Main news

 

 

 

CGM Use, GLP-1s, Drinking Water Key of 2025 ADA Standards
CGM Use, GLP-1s, Drinking Water Key of 2025 ADA Standards The American Diabetes Association (ADA)’s Standards of Care — 2025 offer new guidance on broader use of continuous glucose monitoring (CGM), use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) beyond weight loss, management of metabolic dysfunction-associated liver disease (MAFLD), plus a strong endorsement for drinking water and much more.

ADA Advises Against Using Compounded GLP-1 RA Medications
ADA Advises Against Using Compounded GLP-1 RA Medications In a new statement, the American Diabetes Association (ADA) has advised against the use of compounded glucagon-like peptide 1 receptor agonist (GLP-1 RA) and dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 RA medication classes.

Editorial Activity

cardiology book

Novel Lipid Therapies: 5 Things to Know
Novel Lipid Therapies: 5 Things to Know The development of novel pharmacotherapies targeting low-density lipoprotein (LDL), lipoprotein a, and triglycerides (TG) to help prevent patients' risk of atherosclerotic cardiovascular disease (ASCVD) has accelerated during the past decade.

COVID-19 and cardiovascular diseases: main aspects
COVID-19 and cardiovascular diseases: main aspects Igor S. Yavelov MD, PhD, Professor of cardiology

Administration of patients during and after a coronavirus pandemic. Interview with professor Mekhman N. Mamedov.
Administration of patients during and after a coronavirus pandemic. Interview with professor Mekhman N. Mamedov. Dear Colleagues! On April 27, 2021, at the initiative of the Indonesian Society of Cardiology, an online meeting was held with one of the leading experts of Russia in the cardiology, Professor Mekhman N Mamedov.

Hypertension Clinical Practice Guidelines (ISH, 2020) International Society of Hypertension (ISH)
Hypertension Clinical Practice Guidelines (ISH, 2020) International Society of Hypertension (ISH) The International Society of Hypertension (ISH) released their global recommendations on the management of hypertension in adults aged 18 years and older in June 2020.

Social Isolation Tied to Higher Risk of CV Events, Death
Social Isolation Tied to Higher Risk of CV Events, Death Social isolation is associated with an increased risk of a cardiovascular event of more than 40%, and of all-cause mortality approaching 50%, new research suggests.

Hospital Volumes Slashed by More Than Half During Pandemic
Hospital Volumes Slashed by More Than Half During Pandemic As US hospitals begin to reopen for elective procedures, a new report outlines the damage that the COVID-19 pandemic has done to the facilities' patient volumes and revenues.

COVID-19: AHA Guidance on Hypertension, Latest on Angiotensin Link
COVID-19: AHA Guidance on Hypertension, Latest on Angiotensin Link The American Heart Association (AHA) has issued new guidance for patients with hypertension during the COVID-19 outbreak. At the same time, several new review articles have been published further exploring the possible relationship between the renin-angiotensin system (RAS) and the virus.

СOVID-19 and cardiovascular disease: current articles
СOVID-19 and cardiovascular disease: current articles

Scientific news

  • Accelerated biological ageing and cardiovascular disease trajectories: a multistate analysis Accelerated biological ageing has been linked to elevated risks of hypertension (HTN) and cardiovascular diseases (CVDs), yet its role in shaping the dynamic progression from health to HTN, to CVDs, and ultimately to mortality remains poorly understood. In this regard, the data of 136,614 participants of the UK Biobank aged 38 to 73 years, who did not have hypertension and CVD at the initial stage, were analyzed.
  • Diagnostic performance of exercise stress testing findings and coronary microvascular dysfunction in patients with angina with non-obstructive coronary artery disease Coronary microvascular dysfunction (CMD) is common among patients with angina with non-obstructive coronary artery disease (ANOCA) and leads to poorer clinical outcomes. Exercise stress testing (EST) was shown to have a high specificity for detecting CMD. However, the relationship between diagnosing CMD using different invasive physiological parameters and thresholds and the association between EST findings and the endotype of CMD remains unknown.
  • Engineered blood clots stop bleeding in seconds The blood in the vascular system of the body supports vital functions, but when it leaves the body, it must quickly form a strong protective barrier — a clot that prevents death. However, because natural blood clots are known to form very slowly, heavy bleeding from accidents, battlefield injuries, and surgical complications leads to many potentially preventable deaths. In an article for the journal Nature, Jiang et al. They talked about the achievements of bioengineering that solve this problem by fundamentally changing the structure of blood clots.
  • Cardiac resynchronisation therapy among adults with a systemic right ventricle: a multicentre experience Researchers conducted an international retrospective study including patients over 18 years of age from 33 centers with transposition of the great arteries (TGA) after atrial switch surgery and congenitally corrected TGA.
  • Cardiovascular disease in Sickle cell: mechanisms, diagnostics and therapeutic advances Cardiovascular complications are increasingly recognized as a major cause of morbidity and early mortality in patients with sickle cell disease, yet they remain underdiagnosed and underestimated. In a new review, the authors summarize current knowledge on a wide range of cardiovascular manifestations, including myocardial dysfunction, pulmonary hypertension, cardiac iron overload, arrhythmia, myocardial infarction, stroke, and sudden death, with an emphasis on their unique pathophysiological mechanisms in Wolf-Hirschhorn syndrome.

Partners

Video resource

Channel "Cardioprogress"

Follow us

Top.Mail.Ru